Last updated: 2026-09-07 19:24:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Sera Prognostics, Inc. (SERA) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $2.04, with a market capitalisation of $79.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.56 to $3.95. This page covers its latest market performance, valuation, price trends and company information.
$79.69M | |
$2.00 | |
$15.50 | |
$1.10 | |
$1.98 | |
10.28K | |
35.27K | |
-- | |
$3.95 | |
$1.56 | |
-- | |
-- |
Sera Prognostics, Inc. (SERA) last closed at $1.98 as of 2026-09-04 20:41:00, unchanged from the previous close of $1.98.
During the latest regular trading session, SERA traded between $1.10 and $15.50, with a volume of 10.28K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Sera Prognostics, Inc. (SERA) moved from $2.03 to $2.04, representing a gain of 0.54% ($0.01).
The stock traded between $1.97 and $2.20 during the period. The latest price is near the lower end of the 7-day range, indicating moderate upward.
The average daily volume was 19.99 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 20.1%
SERA is currently trading at $2.04, placing it 20.1% of the way from its 52-week low of $1.56 to its 52-week high of $3.95. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.
| Industry | SERVICES-MEDICAL LABORATORIES |
| Employees | 72 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Sera Prognostics, Inc. (SERA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.